PMID: 16521363Mar 9, 2006Paper

Regulating medicines in Europe: the European Medicines Agency, marketing authorisation, transparency and pharmacovigilance

Clinical Medicine : Journal of the Royal College of Physicians of London
Govin PermanandMartin McKee

Abstract

Following a review process lasting almost four years, and culminating in several pieces of new European legislation, adjustments have been made to the European Union's (EU) regulatory framework for pharmaceuticals. The European Commission laid out its priorities for the review as: simplifying the authorisation system, ensuring a high quality of public health, completing the internal market in medicines, and preparing for the enlargement of the Union. Amongst the most important changes brought about by the new rules are those relating to the European drug approval procedures, the functions and operational transparency of the European Medicines Agency (EMEA), and the EU's pharmacovigilance system. This article provides a brief examination of key elements of these changes, and considers the extent to which they serve the goal of improved public health protection within the EU.

Citations

Mar 1, 2013·Current Diabetes Reports·Sanjay Kalra, Navneet Agrawal
Apr 28, 2010·Advances in Therapy·Steven Simoens
Oct 15, 2013·Journal of Psychosomatic Research·Albert F G Leentjens, James L Levenson
Apr 30, 2013·Journal of Pharmacological and Toxicological Methods·Eric DestexheLawrence Segal
Apr 30, 2013·Journal of Pharmacological and Toxicological Methods·Peter ElfordRoy Forster
Sep 4, 2013·Epilepsy & Behavior : E&B·Vicente VillanuevaMontserrat Asensio
Apr 26, 2008·BMJ : British Medical Journal·Helena Legido-QuigleyNiek Klazinga
Dec 18, 2009·BMC Public Health·Carmen Martín-MadrazoSonia Soto-Diaz
Mar 1, 2009·Therapeutic Advances in Neurological Disorders·Ozgür Yaldizli, Norman Putzki
Aug 17, 2019·European Journal of Heart Failure·Jasper TrompCarolyn S P Lam
Nov 28, 2019·Journal of Medical Internet Research·Maria KarampelaMinna Isomursu
Nov 26, 2009·Beilstein Journal of Organic Chemistry·Kirill PopovJulian Volovenko
Sep 24, 2019·Journal of Clinical Pharmacy and Therapeutics·Hsiao-Huai KuoLawrence Yu-Min Liu
Feb 12, 2020·Pharmacoepidemiology and Drug Safety·Ulrike GeorgiStefanie Deckert
Mar 15, 2020·Cancer Chemotherapy and Pharmacology·Aurélie LombardKayode Ogungbenro
Dec 24, 2010·European Journal of Haematology·Dietger Niederwieser, Stephan Schmitz
Jun 14, 2018·Therapeutic Innovation & Regulatory Science·Annegret Vaggelas, Diane Seimetz
Oct 28, 2017·Expert Opinion on Drug Safety·Igho J OnakpoyaJeffrey K Aronson
Nov 8, 2018·BMJ : British Medical Journal·Robin E Ferner, Patricia McGettigan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.